Matches in Wikidata for { <http://www.wikidata.org/entity/Q91633859> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91633859 description "article scientifique publié en 2019" @default.
- Q91633859 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91633859 description "scientific article published on 03 July 2019" @default.
- Q91633859 description "wetenschappelijk artikel" @default.
- Q91633859 description "наукова стаття, опублікована 3 липня 2019" @default.
- Q91633859 name "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 name "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 type Item @default.
- Q91633859 label "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 label "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 prefLabel "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 prefLabel "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 P1433 Q91633859-23CFE265-3C9A-4CB2-8189-29483B2088B8 @default.
- Q91633859 P1476 Q91633859-2B441C5B-488A-48CF-85B9-90BAA870D7AE @default.
- Q91633859 P2093 Q91633859-378B3858-0679-4B74-8FE1-ED07CA2E403C @default.
- Q91633859 P2093 Q91633859-49E8B9B6-5698-4953-9851-E360D8E5DD19 @default.
- Q91633859 P2093 Q91633859-5531CE75-5178-4219-B539-645D189EEF06 @default.
- Q91633859 P2093 Q91633859-9E0852FF-6FA6-4A76-A3BA-FC78DDCD8562 @default.
- Q91633859 P2093 Q91633859-B138B1D5-C4F4-4718-A00F-E168B87CA3F7 @default.
- Q91633859 P2093 Q91633859-BF42C63F-6333-42EB-8B10-620B815FAA52 @default.
- Q91633859 P2093 Q91633859-FC7BB345-FDEF-428E-8B29-F38D0E9659C7 @default.
- Q91633859 P31 Q91633859-95D54346-4746-4A8F-B9A7-F8B7D5AD9863 @default.
- Q91633859 P356 Q91633859-94F520DC-1EC5-4E32-8614-23E4F452DD55 @default.
- Q91633859 P577 Q91633859-A621803C-BFDD-4BC1-9FA4-FFD82ABDBCD5 @default.
- Q91633859 P698 Q91633859-AB366B3D-71B9-416D-84BE-FAE4FBB16DDB @default.
- Q91633859 P921 Q91633859-38AE04FD-A939-4851-8D26-1510851ADF24 @default.
- Q91633859 P921 Q91633859-65F9661C-1142-40FA-BD90-04B5F5459E6B @default.
- Q91633859 P921 Q91633859-F765362F-426C-4BB0-B003-375E2E729CE9 @default.
- Q91633859 P921 Q91633859-FA1E0449-A970-443D-807E-63D977F7BB31 @default.
- Q91633859 P356 MPH.0000000000001550 @default.
- Q91633859 P698 31274669 @default.
- Q91633859 P1433 Q15761808 @default.
- Q91633859 P1476 "Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease" @default.
- Q91633859 P2093 "Masaki Kusuda" @default.
- Q91633859 P2093 "Shunsuke Nakagawa" @default.
- Q91633859 P2093 "Takuro Mitsunobu" @default.
- Q91633859 P2093 "Takuro Nishikawa" @default.
- Q91633859 P2093 "Yasuhiro Okamoto" @default.
- Q91633859 P2093 "Yoshifumi Kawano" @default.
- Q91633859 P2093 "Yuichi Kodama" @default.
- Q91633859 P31 Q13442814 @default.
- Q91633859 P356 "10.1097/MPH.0000000000001550" @default.
- Q91633859 P577 "2019-07-03T00:00:00Z" @default.
- Q91633859 P698 "31274669" @default.
- Q91633859 P921 Q422232 @default.
- Q91633859 P921 Q486090 @default.
- Q91633859 P921 Q5062122 @default.
- Q91633859 P921 Q6488977 @default.